ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 823

$605K Total Retail Price of All Prescriptions

Rank: 70 out of 823

368 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 10,020 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 679 606 1 2
AMLODIPINE BESYLATE 538 499 2 3
LEVOTHYROXINE SODIUM 428 402 3 6
LISINOPRIL 380 337 4 4
LOSARTAN POTASSIUM 331 275 5 26
OMEPRAZOLE 331 273 5 5
ATORVASTATIN CALCIUM 321 288 7 13
METOPROLOL TARTRATE 301 292 8 11
FUROSEMIDE 274 239 9 7
METFORMIN HCL 233 196 10 14
METFORMIN HCL ER 216 184 11 94
GABAPENTIN 211 160 12 8
FENOFIBRATE 207 157 13 152
WARFARIN SODIUM 177 145 14 18
GLIMEPIRIDE 154 153 15 51
SERTRALINE HCL 148 120 16 38
FLUTICASONE PROPIONATE 145 128 17 50
METOPROLOL SUCCINATE 141 119 18 9
CLOPIDOGREL 139 130 19 16
CITALOPRAM HBR 124 119 20 34
HYDROCODONE-ACETAMINOPHEN 119 101 S3 21 1
ATENOLOL 116 115 22 47
CARVEDILOL 112 86 23 12
POTASSIUM CHLORIDE 111 107 24 22
ACTONEL 108 104 25 228
LOSARTAN-HYDROCHLOROTHIAZIDE 105 89 26 57
TAMSULOSIN HCL 101 97 27 21
TRAMADOL HCL 96 91 28 15
ESCITALOPRAM OXALATE 95 94 29 99
HYDROCHLOROTHIAZIDE 91 76 30 29
AMLODIPINE BESYLATE-BENAZEPRIL 90 78 31 81
DONEPEZIL HCL 90 90 31 24
PLAVIX 89 81 33 25
LANTUS SOLOSTAR 88 56 34 129
DIOVAN 88 87 34 35
EVISTA 85 85 36 212
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 67 37 39
LANTUS 83 69 37 76
PRAVASTATIN SODIUM 81 77 39 23
ZOLPIDEM TARTRATE 78 56 40 17
SYNTHROID 78 78 40 37
DILTIAZEM ER 77 77 42 451
ALLOPURINOL 74 62 43 61
CIPROFLOXACIN HCL 72 56 44 32
ZETIA 71 71 45 100
VERAPAMIL ER 67 61 46 171
MELOXICAM 65 62 47 27
VENTOLIN HFA 64 55 48 242
TRIAMTERENE-HCTZ 60 58 49 138
LOVASTATIN 57 52 50 132
ALENDRONATE SODIUM 57 50 50 42
ADVAIR DISKUS 55 48 52 68
WELCHOL 52 52 53 298
AZITHROMYCIN 52 43 53 48
SPIRONOLACTONE 52 44 53 72
LORAZEPAM 51 51 56 514
NEXIUM 51 51 56 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.